Target type: biologicalprocess
Any process involved in the activation of any of the steps of the alternative pathway of the complement cascade which allows for the direct killing of microbes and the regulation of other immune processes. [GOC:add, ISBN:0781735149]
The alternative pathway of complement activation is a crucial component of the innate immune system, acting as a first line of defense against pathogens. It differs from the classical and lectin pathways in its initiation, relying on spontaneous activation rather than antibody or lectin recognition.
The process begins with the spontaneous hydrolysis of C3, a central complement protein. This hydrolysis exposes a reactive thioester bond on C3, allowing it to bind to a variety of surfaces, including microbial cell walls. This initial binding forms a complex known as C3(H2O), which is unstable and quickly degraded. However, in the presence of certain microbial surfaces, such as lipopolysaccharide (LPS) from gram-negative bacteria, C3(H2O) can interact with Factor B, a serum protein.
Factor B binds to C3(H2O) and undergoes a conformational change that allows it to be cleaved by Factor D, a serine protease present in the serum. This cleavage results in the formation of two fragments: Ba, which is released, and Bb, which remains bound to C3(H2O). This complex, known as C3(H2O)Bb, is the alternative pathway C3 convertase.
The C3 convertase, C3(H2O)Bb, is unstable and rapidly degraded. However, it can bind to another molecule of C3, cleaving it into C3a and C3b. C3b, the larger fragment, can then bind to the surface of the microbial cell, forming a new C3 convertase complex known as C3bBb. This complex is more stable and amplifies the activation process, leading to the deposition of multiple C3b molecules on the target surface.
The deposited C3b can then interact with Factor P (properdin), a stabilizing protein that increases the stability and half-life of the C3 convertase. This further amplifies the complement cascade.
Ultimately, the deposition of C3b on the microbial cell surface leads to the formation of the alternative pathway C5 convertase, composed of C3b2Bb. This enzyme cleaves C5 into C5a and C5b. C5b initiates the formation of the membrane attack complex (MAC), a complex of complement proteins that forms pores in the microbial cell membrane, leading to cell lysis and death.
In addition to its role in microbial killing, the alternative pathway plays a critical role in opsonization, the process by which microbial cells are marked for destruction by phagocytes. The deposited C3b acts as an opsonin, binding to receptors on phagocytes and facilitating the engulfment and destruction of the pathogen.
The alternative pathway is tightly regulated to prevent uncontrolled activation and potential damage to host tissues. Regulatory proteins, such as Factor H and Factor I, bind to C3b, promoting its inactivation and preventing the formation of the C3 convertase. This regulatory mechanism ensures that the complement system is activated only in the presence of pathogens, minimizing the risk of collateral damage to host cells.'
"
Protein | Definition | Taxonomy |
---|---|---|
Complement factor B | A complement factor B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00751] | Homo sapiens (human) |
Complement factor D | A complement factor D that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00746] | Homo sapiens (human) |
Complement component C9 | A complement component C9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P02748] | Homo sapiens (human) |
Complement C5 | A complement C5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01031] | Homo sapiens (human) |
Complement C3 | A complement C3 that is encoded in the genome of human. [UniProtKB:P01024] | Homo sapiens (human) |
Complement factor B | A complement factor B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00751] | Homo sapiens (human) |
Complement factor D | A complement factor D that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00746] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aurintricarboxylic acid | aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'. Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
carprofen | carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs. carprofen: RN given refers to cpd without isomeric designation | carbazoles; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; photosensitizing agent |
oxaprozin | oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis. Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE. | 1,3-oxazoles; monocarboxylic acid | analgesic; non-steroidal anti-inflammatory drug |
raloxifene | raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively. | 1-benzothiophenes; aromatic ketone; N-oxyethylpiperidine; phenols | bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
isatoic anhydride | isatoic anhydride: structure given in first source | ||
sulindac | sulindac : A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions. Sulindac: A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects. | monocarboxylic acid; organofluorine compound; sulfoxide | analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent |
compstatin | compstatin: binds to complement 3; amino acid sequence in first source |